Måndag 16 Februari | 02:42:50 Europe / Stockholm

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-01-27 08:16:00

Pila Pharma is advancing its clinical ambitions in the obesity segment. The company announced that it has signed an agreement with a new clinical Contract Research Organisation (CRO) to prepare for a new clinical trial in obesity. The decision to move forward comes after recent preclinical studies in obesity yielded inconclusive results.

Read the full article at biostock.se:
https://biostock.se/en/2026/01/pila-pharma-forbereder-klinisk-obesitasstudie-trots-inkonklusiva-prekliniska-data/
This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se